Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
344 studies found for:    "primary pulmonary hypertension"
Show Display Options
Rank Status Study
21 Withdrawn Safety and Efficacy of Inhaled Iloprost in Pediatric Patients With Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Iloprost Inhalation Solution (Ventavis)
22 Not yet recruiting The Combination Ambrisentan Plus Spironolactone in Pulmonary Arterial Hypertension Study
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Ambrisentan plus Spironolactone;   Drug: Ambrisentan plus Placebo
23 Completed
Has Results
Epoprostenol for Injection in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: ACT-385781A (Actelion Epoprostenol);   Drug: Flolan®
24 Recruiting Bardoxolone Methyl Evaluation in Patients With Pulmonary Arterial Hypertension (PAH) - LARIAT
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Bardoxolone methyl;   Drug: Placebo
25 Terminated
Has Results
Iloprost Power Disc-15 in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Iloprost PD-6;   Drug: Iloprost PD-15
26 Active, not recruiting Selexipag (ACT-293987) in Pulmonary Arterial Hypertension, GRIPHON Trial
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Selexipag (ACT-293987);   Drug: Placebo
27 Recruiting Peripheral Muscle Microcirculation and Exercise-induced Blood Flow Distribution in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Other: Submaximal exercises
28 Recruiting Transforming Growth Factor Beta Signalling in the Development of Muscle Weakness in Pulmonary Arterial Hypertension
Conditions: Muscle Weakness;   Pulmonary Arterial Hypertension
Intervention:
29 Recruiting Feasibility of Slow-paced Respiration Therapy for Treatment of a Symptom Cluster in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Other: Slow-paced respiration therapy
30 Completed
Has Results
Imatinib (QTI571) in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: imatinib mesylate;   Drug: Placebo
31 Completed
Has Results
Epoprostenol for Injection in Pulmonary Arterial Hypertension - Extension of AC-066A401
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: ACT-385781A (Actelion Epoprostenol);   Drug: Flolan®
32 Active, not recruiting Compassionate Use of Beraprost Sodium 314d Modified Release for Patients With Pulmonary Arterial Hypertension (PAH)
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: BPS-314d-MR
33 Completed
Has Results
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: iloprost
34 Active, not recruiting Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)
Conditions: Pulmonary Arterial Hypertension;   Pulmonary Hypertension
Interventions: Drug: Nitric Oxide;   Other: Placebo
35 Terminated Long-term Study of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension Who Completed AIR001-CS05
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: AIR001
36 Terminated Study of Intravenous Remodulin in Patients in India With Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Remodulin (treprostinil sodium)
37 Terminated A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: AIR001 (sodium nitrite inhalation solution)
38 Completed
Has Results
Pilot Chart Review Study Of Sitaxentan Sodium (Thelin) In Patients With Pulmonary Arterial Hypertension (PAH)
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Sitaxentan sodium
39 Terminated
Has Results
Efficacy, Safety, Tolerability and Pharmacokinetics (PK) of Nilotinib (AMN107) in Pulmonary Arterial Hypertension (PAH)
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Nilotinib;   Drug: Placebo to nilotinib
40 Unknown  Effects of Iloprost Treatment in Adult Patients With Pulmonary Arterial Hypertension Related to Congenital Heart Disease
Condition: Pulmonary Arterial Hypertension
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years